| Yong Kang, MD | |
|
Monmouth Medical Center Dept Of Pathology, 300 Second Avenue, Long Branch, NJ 07740 | |
| (732) 229-8711 | |
| (732) 229-0245 |
| Full Name | Yong Kang |
|---|---|
| Gender | Male |
| Speciality | Pathology |
| Experience | 40 Years |
| Location | Monmouth Medical Center Dept Of Pathology, Long Branch, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1609932433 | NPI | - | NPPES |
| 8570507 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207ZP0102X | Pathology - Anatomic Pathology & Clinical Pathology | MA 72410 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Monmouth Medical Center | Long branch, NJ | Hospital |
| Monmouth Medical Center - Southern Campus | Lakewood, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Rutgers Health-rwj Pediatric Critical Care | 1355390287 | 143 |
News Archive
Michigan Attorney General Mike Cox announced today a settlement with pharmaceutical manufacturer Schering Plough over its underpayment of Medicaid Drug Rebates on the antihistamine drug Claritin, netting more than $2.6 million for Michigan's Medicaid program.
His State Of The Union comments will likely highlight the different partisan views on how these automatic spending cuts, set to kick in March 1, could be minimized. Republicans continue to press for changes in entitlement programs, such as Medicare.
Neurological symptoms have been widely reported in patients with COVID-19 and in those who have recovered from it. A new study led by Thomas Wisniewski of New York University Grossman School of Medicine, USA, finds that patients hospitalized with COVID-19 are more likely to have elevated biomarkers levels indicative of age-related neurodegeneration.
Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.
› Verified 3 days ago
| Entity Name | Rutgers Health-rwj Pathology |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1538173539 PECOS PAC ID: 8921090663 Enrollment ID: O20040401000743 |
News Archive
Michigan Attorney General Mike Cox announced today a settlement with pharmaceutical manufacturer Schering Plough over its underpayment of Medicaid Drug Rebates on the antihistamine drug Claritin, netting more than $2.6 million for Michigan's Medicaid program.
His State Of The Union comments will likely highlight the different partisan views on how these automatic spending cuts, set to kick in March 1, could be minimized. Republicans continue to press for changes in entitlement programs, such as Medicare.
Neurological symptoms have been widely reported in patients with COVID-19 and in those who have recovered from it. A new study led by Thomas Wisniewski of New York University Grossman School of Medicine, USA, finds that patients hospitalized with COVID-19 are more likely to have elevated biomarkers levels indicative of age-related neurodegeneration.
Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.
› Verified 3 days ago
| Entity Name | Rutgers Health-rwj Pediatric Critical Care |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780766527 PECOS PAC ID: 1355390287 Enrollment ID: O20050119000070 |
News Archive
Michigan Attorney General Mike Cox announced today a settlement with pharmaceutical manufacturer Schering Plough over its underpayment of Medicaid Drug Rebates on the antihistamine drug Claritin, netting more than $2.6 million for Michigan's Medicaid program.
His State Of The Union comments will likely highlight the different partisan views on how these automatic spending cuts, set to kick in March 1, could be minimized. Republicans continue to press for changes in entitlement programs, such as Medicare.
Neurological symptoms have been widely reported in patients with COVID-19 and in those who have recovered from it. A new study led by Thomas Wisniewski of New York University Grossman School of Medicine, USA, finds that patients hospitalized with COVID-19 are more likely to have elevated biomarkers levels indicative of age-related neurodegeneration.
Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Yong Kang, MD Po Box 417, 279 Third Ave Suite 104, Long Branch, NJ 07740 Ph: (732) 229-8711 | Yong Kang, MD Monmouth Medical Center Dept Of Pathology, 300 Second Avenue, Long Branch, NJ 07740 Ph: (732) 229-8711 |
News Archive
Michigan Attorney General Mike Cox announced today a settlement with pharmaceutical manufacturer Schering Plough over its underpayment of Medicaid Drug Rebates on the antihistamine drug Claritin, netting more than $2.6 million for Michigan's Medicaid program.
His State Of The Union comments will likely highlight the different partisan views on how these automatic spending cuts, set to kick in March 1, could be minimized. Republicans continue to press for changes in entitlement programs, such as Medicare.
Neurological symptoms have been widely reported in patients with COVID-19 and in those who have recovered from it. A new study led by Thomas Wisniewski of New York University Grossman School of Medicine, USA, finds that patients hospitalized with COVID-19 are more likely to have elevated biomarkers levels indicative of age-related neurodegeneration.
Teva Pharmaceutical Industries Ltd. and CureTech, a portfolio company of Teva and Clal Biotechnology Industries announced today preliminary topline results for CT-011, an investigational anti-PD-1 monoclonal antibody.
› Verified 3 days ago
Dr. Hua Zhong, M.D., PH.D. Pathology Medicare: Accepting Medicare Assignments Practice Location: 300 2nd Ave, Long Branch, NJ 07740 Phone: 732-923-7360 Fax: 732-923-7355 | |
Wendy T Shertz-dipietro, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 300 Second Avenue, Monmouth Medical Center Dept Of Pathology, Long Branch, NJ 07740 Phone: 732-229-8711 Fax: 732-229-0245 | |
Abraham Loo, MD Pathology Medicare: Accepting Medicare Assignments Practice Location: 300 2nd Ave, Monmouth Medical Center Department Of Pathology, Long Branch, NJ 07740 Phone: 732-923-7352 | |
Louis J Zinterhofer, MD PHD Pathology Medicare: Not Enrolled in Medicare Practice Location: Monmouth Medical Center Dept Of Pathology, 300 Second Avenue, Long Branch, NJ 07740 Phone: 732-229-8711 Fax: 732-229-0245 |